Cargando…
Prevalence of SARS-CoV-2 infection and associated risk factors among asylum seekers living in asylum centres: A cross-sectional serologic study in Canton of Vaud, Switzerland
BACKGROUND: Understanding the factors influencing SARS-CoV-2 transmission in asylum seekers and refugees living in centres is crucial to determine targeted public health policies protecting these populations fairly and efficiently. In response, this study was designed to explore the pandemic's...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10005972/ https://www.ncbi.nlm.nih.gov/pubmed/36938329 http://dx.doi.org/10.1016/j.jmh.2023.100175 |
_version_ | 1784905208122310656 |
---|---|
author | Morisod, Kevin Grazioli, Véronique S. Schlüter, Virginie Bochud, Murielle Gonseth Nusslé, Semira D'Acremont, Valérie Bühler, Nolwenn Bodenmann, Patrick |
author_facet | Morisod, Kevin Grazioli, Véronique S. Schlüter, Virginie Bochud, Murielle Gonseth Nusslé, Semira D'Acremont, Valérie Bühler, Nolwenn Bodenmann, Patrick |
author_sort | Morisod, Kevin |
collection | PubMed |
description | BACKGROUND: Understanding the factors influencing SARS-CoV-2 transmission in asylum seekers and refugees living in centres is crucial to determine targeted public health policies protecting these populations fairly and efficiently. In response, this study was designed to explore the pandemic's spread into asylum centres during the first wave of the pandemic in Switzerland. Specifically, it aimed to identify the risk factors associated with a positive anti-SARS-CoV-2 seroprevalence test after the first semi-confinement period (16 March to 27 April 2020) amongst asylum seekers and refugees living in centres. METHODS: This research is part of SérocoVID, a seroepidemiologic study of SARS-CoV-2 infection conducted in the canton of Vaud, Switzerland. Migrants living in two asylum centres, one known to have had an epidemic outbreak, were invited to participate in this study. Anti-SARS-CoV-2 IgG and IgA antibodies targeting the spike viral protein were measured in all participants using a Luminex immunoassay. Each participant also completed a questionnaire measuring socio-demographic characteristics, medical history (comorbidities, smoking status, BMI, flu-like symptoms), health literacy, public health recommendations (wearing a masque in a public area, social distancing and hands cleaning), behaviours and exposures (daily life activities, number of contacts weekly). The association of these independent variables with the serologic test result were estimated using a multivariable logistic regression model. FINDINGS: A total of 124 participants from the two asylum centres took part in the study (Centre 1, n = 82; Centre 2, n = 42). The mean participation rate was 36.7%. The seroprevalence in Centres 1 and 2 were 13% [95% CI 0.03, 0.14] and 50% [0.34, 0.65], respectively. Next, 40.63% of SARS-CoV-2 positive people never developed symptoms (asymptomatic cases), and no one had severe forms of the Covid-19 disease requiring hospitalisation. Participants report high compliance with public health measures, especially hygiene rules (96.3% of positive answers) and social distancing (88.7%). However, only 11.3% said they always wore a masque in public. After adjusting for individual characteristics, infection risk was lower amongst people with high health literacy (aOR 0.16, p = 0.007 [0.04, 0.60]) and smokers (aOR 0.20, p = 0.013 [0.06, 0.69]). CONCLUSION: Despite the lack of severe complications of Covid-19 disease in this study, findings suggest that developing targeted public health measures, especially for the low health literacy population, would be necessary to limit the risk of outbreaks in asylum centres and improve this population's safety. Further investigations and qualitative approach are required to understand more finely how living conditions, risks and behaviours such as tobacco consumption, and the adoption of protective measures impact SARS-CoV-2 infection. |
format | Online Article Text |
id | pubmed-10005972 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-100059722023-03-13 Prevalence of SARS-CoV-2 infection and associated risk factors among asylum seekers living in asylum centres: A cross-sectional serologic study in Canton of Vaud, Switzerland Morisod, Kevin Grazioli, Véronique S. Schlüter, Virginie Bochud, Murielle Gonseth Nusslé, Semira D'Acremont, Valérie Bühler, Nolwenn Bodenmann, Patrick J Migr Health Article BACKGROUND: Understanding the factors influencing SARS-CoV-2 transmission in asylum seekers and refugees living in centres is crucial to determine targeted public health policies protecting these populations fairly and efficiently. In response, this study was designed to explore the pandemic's spread into asylum centres during the first wave of the pandemic in Switzerland. Specifically, it aimed to identify the risk factors associated with a positive anti-SARS-CoV-2 seroprevalence test after the first semi-confinement period (16 March to 27 April 2020) amongst asylum seekers and refugees living in centres. METHODS: This research is part of SérocoVID, a seroepidemiologic study of SARS-CoV-2 infection conducted in the canton of Vaud, Switzerland. Migrants living in two asylum centres, one known to have had an epidemic outbreak, were invited to participate in this study. Anti-SARS-CoV-2 IgG and IgA antibodies targeting the spike viral protein were measured in all participants using a Luminex immunoassay. Each participant also completed a questionnaire measuring socio-demographic characteristics, medical history (comorbidities, smoking status, BMI, flu-like symptoms), health literacy, public health recommendations (wearing a masque in a public area, social distancing and hands cleaning), behaviours and exposures (daily life activities, number of contacts weekly). The association of these independent variables with the serologic test result were estimated using a multivariable logistic regression model. FINDINGS: A total of 124 participants from the two asylum centres took part in the study (Centre 1, n = 82; Centre 2, n = 42). The mean participation rate was 36.7%. The seroprevalence in Centres 1 and 2 were 13% [95% CI 0.03, 0.14] and 50% [0.34, 0.65], respectively. Next, 40.63% of SARS-CoV-2 positive people never developed symptoms (asymptomatic cases), and no one had severe forms of the Covid-19 disease requiring hospitalisation. Participants report high compliance with public health measures, especially hygiene rules (96.3% of positive answers) and social distancing (88.7%). However, only 11.3% said they always wore a masque in public. After adjusting for individual characteristics, infection risk was lower amongst people with high health literacy (aOR 0.16, p = 0.007 [0.04, 0.60]) and smokers (aOR 0.20, p = 0.013 [0.06, 0.69]). CONCLUSION: Despite the lack of severe complications of Covid-19 disease in this study, findings suggest that developing targeted public health measures, especially for the low health literacy population, would be necessary to limit the risk of outbreaks in asylum centres and improve this population's safety. Further investigations and qualitative approach are required to understand more finely how living conditions, risks and behaviours such as tobacco consumption, and the adoption of protective measures impact SARS-CoV-2 infection. Elsevier 2023-03-11 /pmc/articles/PMC10005972/ /pubmed/36938329 http://dx.doi.org/10.1016/j.jmh.2023.100175 Text en © 2023 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Article Morisod, Kevin Grazioli, Véronique S. Schlüter, Virginie Bochud, Murielle Gonseth Nusslé, Semira D'Acremont, Valérie Bühler, Nolwenn Bodenmann, Patrick Prevalence of SARS-CoV-2 infection and associated risk factors among asylum seekers living in asylum centres: A cross-sectional serologic study in Canton of Vaud, Switzerland |
title | Prevalence of SARS-CoV-2 infection and associated risk factors among asylum seekers living in asylum centres: A cross-sectional serologic study in Canton of Vaud, Switzerland |
title_full | Prevalence of SARS-CoV-2 infection and associated risk factors among asylum seekers living in asylum centres: A cross-sectional serologic study in Canton of Vaud, Switzerland |
title_fullStr | Prevalence of SARS-CoV-2 infection and associated risk factors among asylum seekers living in asylum centres: A cross-sectional serologic study in Canton of Vaud, Switzerland |
title_full_unstemmed | Prevalence of SARS-CoV-2 infection and associated risk factors among asylum seekers living in asylum centres: A cross-sectional serologic study in Canton of Vaud, Switzerland |
title_short | Prevalence of SARS-CoV-2 infection and associated risk factors among asylum seekers living in asylum centres: A cross-sectional serologic study in Canton of Vaud, Switzerland |
title_sort | prevalence of sars-cov-2 infection and associated risk factors among asylum seekers living in asylum centres: a cross-sectional serologic study in canton of vaud, switzerland |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10005972/ https://www.ncbi.nlm.nih.gov/pubmed/36938329 http://dx.doi.org/10.1016/j.jmh.2023.100175 |
work_keys_str_mv | AT morisodkevin prevalenceofsarscov2infectionandassociatedriskfactorsamongasylumseekerslivinginasylumcentresacrosssectionalserologicstudyincantonofvaudswitzerland AT grazioliveroniques prevalenceofsarscov2infectionandassociatedriskfactorsamongasylumseekerslivinginasylumcentresacrosssectionalserologicstudyincantonofvaudswitzerland AT schlutervirginie prevalenceofsarscov2infectionandassociatedriskfactorsamongasylumseekerslivinginasylumcentresacrosssectionalserologicstudyincantonofvaudswitzerland AT bochudmurielle prevalenceofsarscov2infectionandassociatedriskfactorsamongasylumseekerslivinginasylumcentresacrosssectionalserologicstudyincantonofvaudswitzerland AT gonsethnusslesemira prevalenceofsarscov2infectionandassociatedriskfactorsamongasylumseekerslivinginasylumcentresacrosssectionalserologicstudyincantonofvaudswitzerland AT dacremontvalerie prevalenceofsarscov2infectionandassociatedriskfactorsamongasylumseekerslivinginasylumcentresacrosssectionalserologicstudyincantonofvaudswitzerland AT buhlernolwenn prevalenceofsarscov2infectionandassociatedriskfactorsamongasylumseekerslivinginasylumcentresacrosssectionalserologicstudyincantonofvaudswitzerland AT bodenmannpatrick prevalenceofsarscov2infectionandassociatedriskfactorsamongasylumseekerslivinginasylumcentresacrosssectionalserologicstudyincantonofvaudswitzerland |